Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

The course and progression of prostate cancer is highly variable, depending on the individual characteristics, the aggressiveness of the disease at the time of diagnosis as well as the ethno-geographic origins of the individuals. The general objective of the project is to identify the clinical, genetic and environmental determinants (risk factors) of the evolution, progression and complications of the disease according to the treatment options. Identifying modifiable and non-modifiable prognostic determinants of disease progression is a major challenge. This knowledge will help guide treatment choices but also, especially in high-risk populations (high incidence of disease) to better tailor prevention policies and possibly screening .

NCT Number	NCT06046131
Lead Sponsor	Centre Hospitalier Universitaire de la Guadeloupe Collaborators: Institut National de la Santé Et de la Recherche Médicale, France
Conditions	Prostatic Neoplasm, Adenocarcinoma, Neoplasm Recurrence, Neoplasm Metastasis
Enrollment	3,000 participants
Start Date	2023-02-28
Primary Completion	2039-02-28 (estimated)
Study Completion	2039-02-28 (estimated)
Updated on ClinicalTrials.gov	2025-11-17